Navigation Links
Scandal Exposed in Major Study of Autism and Mercury
Date:10/25/2011

SILVER SPRING, Md., Oct. 25, 2011 /PRNewswire-USNewswire/ -- The Coalition for Mercury-free Drugs (CoMeD) exposes communications between Centers for Disease Control (CDC) personnel and vaccine researchers revealing U.S. officials apparently colluded in covering-up the decline in Denmark's autism rates following the removal of mercury from vaccines.

Documents obtained via the Freedom of Information Act (FOIA) show that CDC officials were aware of Danish data indicating a connection between removing Thimerosal (49.55% mercury) and a decline in autism rates.  Despite this knowledge, these officials allowed a 2003 article to be published in Pediatrics that excluded this information, misrepresented the decline as an increase, and led to the mistaken conclusion that Thimerosal in vaccines does not cause autism.  

In Denmark, Thimerosal, a controversial mercury compound used as a preservative in certain vaccines, was removed from all Danish vaccines in 1992.  The well-publicized Danish study published in Pediatrics 2003 claimed that autism rates actually increased after Thimerosal was phased out.  This study subsequently became a cornerstone for the notion that mercury does not cause autism.  However, one of the FOIA documents obtained from CDC clearly indicates that this study omitted large amounts of data showing autism rates actually dropping after mercury was removed from Danish vaccines.  

One coauthor, from Aarhus University, Denmark, was aware of the omission and alerted CDC officials in a 2002 email, stating "Attached I send you the short and long manuscript about Thimerosal and autism in Denmark … I need to tell you that the figures do not include the latest data from 2001 … but the incidence and prevalence are still decreasing in 2001" (emphasis added).  

We know the article's lead author was aware of the missing autism data because he stated in an email reply, "I am not currently at the university but I will contact you and <names withheld> tomorrow to make up our minds."

Nevertheless, in the final draft version of the publication submitted to Pediatrics, the data from 2001 showing a decline in autism was not mentioned.  Ignoring this omission, the CDC continued to endorse the article and, in a December 10, 2002 recommendation letter to the editor of Pediatrics, encouraged expedited review and publication of the article.  The misleading Danish article was published by Pediatrics in 2003.

Dr. Poul Thorsen, one of the co-authors and "scientist in residence" at the CDC 2000-2002, subsequently was terminated by Aarhus University and indicted in Atlanta for embezzlement this year in relation to his $11 million grant from the CDC.

CoMeD has demanded that the CDC launch an immediate investigation of the CDC officials involved based on scientific fraud.  CoMeD is also calling for the full retraction of the deceptive article which appeared in Pediatrics.  

"This type of malfeasance should not be tolerated by those who are entrusted with our children's health and well-being," stated Lisa Sykes, President of CoMeD.


'/>"/>
SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wrestlers Are 16 Times More Likely to Be Exposed to MRSA During Tournament Season
2. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
3. Endoscopy Devices Market in Emerging Economies (India, China, Brazil) - Growing Investments in Hospitals to be the Major Growth Driver
4. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
5. China Medical Technologies Announces the Approval of the Renewed High and New Technology Enterprise Status for a Major Subsidiary in China
6. DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill" Catheterization Technique to Remove a Major Blockage
7. Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT® MRI
8. MDC Partners Launches Integrated Healthcare Marketing Platform With Acquisition of Majority Stake in Concentric Pharma Advertising
9. Seattle Childrens Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year
10. Global Standardization for Alzheimers Biomarkers Moves a Major Step Closer to Reality
11. National Survey Shows: Vast Majority of Preteens and Teens Engage in Activities That May Put Them at Risk for Contracting Meningitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
(Date:3/27/2017)... 2017  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical ... diseases in children, today reported financial results for ... 31, 2016 and provided an update on its ... make progress during the fourth quarter of 2016 ... primate safety study, and with our lead development ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... it will co-exhibit with technology partners LG Business Solutions at ATARC Federal ... Center in Washington D.C., will provide education and examination into the mobility tools ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, ... coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business ... the April edition of American Veterinarian™. , “We look forward to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider ... a row; they are the recipient of the prestigious “Best Overall Design Strategy ... award at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... testing methods are complicated and require expert user knowledge. In a live webinar ... dedicated to the simplified, yet highly accurate, determination of sodium. , It has ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... The ... and the number of homeowners utilizing DIY and unlicensed contractors for renovations is also ... remodel or replacement project in 2015, and of those, 42% failed to use a ...
Breaking Medicine News(10 mins):